count	pubmed_id	drug	atc	phenotype	measured_phenotype	in_vitro	drug_list	consortium	notes	Curator	
1	18521091	iloperidone	N05AX14	side effects	QT prolongation			N/A		G	
1	18535201	warfarin	B01AA03	efficacy	maintenance dose			N/A		G	
1	18591461	Thiazides, plain	C03AA	efficacy	blood pressure			N/A		G	
1	18615156	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score		etanercept, infliximab, adalimumab	ABCoN		G	
1	18650507	simvastatin	C10AA01	side effects	statin-induced myopathy		simvastatin	SEARCH		G	
1	19176441	ANTINEOPLASTIC AGENTS	L01	efficacy	Minimal residual disease at the end of induction therapy, measured by flow cytometry		mixed, methotrexate	SJCRH		G	
1	19300499	warfarin	B01AA03	efficacy	maintenance dose			WARG		G	
1	19578179	acenocoumarol	B01AA07	efficacy	maintenance dose			Rotterdam		G	
1	19680635	ANTIPSYCHOTICS	N05A	side effects	incidence of side effects		perphenazine, olanzapine, risperidone, quetiapine, clozapine, ziprazidone	CATIE, CATIE-GWAS		G	
1	19684573	Hepatitis vaccine combinations	J07BC20	efficacy	sustained virologic response			N/A		Y	
1	19706858	clopidogrel	B01AC04	efficacy	Platelet aggregation			PAPI		G	
1	19721433	ANTIPSYCHOTICS	N05A	efficacy	Positive and Negative Syndrome Scale		perphenazine, olanzapine, risperidone, quetiapine, clozapine, ziprazidone	CATIE		G	
2	19749757	ribavirin	J05AP01	efficacy	null virologic response			N/A	combination therapies	G	
2	19749757	Interferons	L03AB	efficacy	null virologic response		peginterferon alpha-2a, peginterferon alpha-2b	N/A	combination therapies	G	
2	19749758	ribavirin	J05AP01	efficacy	sustained virologic response			N/A	combination therapies	G	
2	19749758	peginterferon alfa-2b	L03AB10	efficacy	sustained virologic response			N/A	combination therapies	G	
1	19846067	citalopram	N06AB04	efficacy	QIDS-SR			STAR*D		G	
1	19875103	ANTIPSYCHOTICS	N05A	side effects	quantitative measures of adverse drug reactions		mixed	CATIE		G	
1	19901119	methotrexate	L01BA01	efficacy	plasma drug concentration			SJCRH		G	
1	20014019	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Harvey Bradshaw Index (HBI) for Crohn's disease (CD) and partial Mayo score for ulcerative colitis (UC)			CSMC		G	
2	20060832	ribavirin	J05AP01	efficacy	null virologic response			Swiss Hepatitis C Cohort Study, Swiss HIV Cohort Study	combination therapies	G	
2	20060832	peginterferon alfa-2b	L03AB10	efficacy	null virologic response			Swiss Hepatitis C Cohort Study, Swiss HIV Cohort Study	combination therapies	G	
1	20195266	ANTIPSYCHOTICS	N05A	side effects	12 indicators of metabolic side effects, quantifying antipsychotic-induced change in weight, blood lipids, glucose and hemoglobin A1c, blood pressure and heart rate		perphenazine, olanzapine, risperidone, quetiapine, clozapine, ziprazidone	CATIE		G	
1	20339536	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	Change in LDL-cholesterol, total cholesterol, HDL cholesterol, and triglycerides		simvastatin, pravastatin, pravastatin	CAP, PRINCE, TNT, 		G	
1	20360315	antidepressants	N06A	efficacy	Change in depression severity. Montgomery-Åsberg Depression Rating Scale		escitilopram, nortriptyline	GENDEP		G	
1	20592726	asparaginase	L01XX02	side effects	local manifestations at injection site and systemic manifestations			SJCRH		G	
1	20637204	ribavirin	J05AP01	side effects	hemoglobin decline		pegylated-interferon alpha, ribavirin	N/A		G	
1	20833655	warfarin	B01AA03	efficacy	maintenance dose			Biobank Japan		G	
1	20876420	Aromatase inhibitors	L02BG	side effects	musculoskeletal adverse event incidence		anastrolzole, exemestane	CALGB, ECOG, IBCSG, PGRN-RIKEN		G	
1	20921969	ANTIPSYCHOTICS	N05A	side effects	QTc interval prolongation		olanzapine, perphenazine, quetiapine, risperidone and ziprasidone	CATIE		G	
2	21079520	paclitaxel	L01CD01	efficacy	survival and treatment response			N/A		Y	
2	21079520	carboplatin	L01XA02	efficacy	survival			N/A		Y	
1	21106707	bleomycin	L01DC01	side effects	number of chromatid breaks after bleomycin treatment			N/A		G	
1	21107309	ANTIPSYCHOTICS	N05A	efficacy	neurocognitive ability (processing speed, verbal memory, vigilance, reasoning, and working memory domains)		perphenazine, olanzapine, risperidone, quetiapine, clozapine, ziprazidone	CATIE		G	
1	21130132	methylphenidate	N06BA04	side effects	blood pressure			N/A		G	
1	21149285	carbamazepine	N03AF01	side effects	Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug-induced hypersensitivity syndrome (DIHS)			Biobank Japan		G	
1	21177773	paracetamol	N02BE01	side effects	in vitro growth inhibitory effect of drug on cell llines	TRUE		N/A		G	
1	21186350	metformin	A10BA02	efficacy	HbA1c levels			DARTS, GoDARTS, UKPDS		G	
1	21386754	cerivastatin	C10AA06	side effects	rhabdomyalysis			HFH, CHS		G	
1	21396408	Influenza vaccines	J07BB	side effects	drug-induced wheezing			N/A		G	
1	21428769	carbamazepine	N03AF01	side effects	carbamazepine-induced hyersensitiviy syndrome			EPIGEN, WTCCC		G	
1	21483023	Platinum compounds, antineoplastic drugs	L01XA	efficacy	survival			PLATAX, Mayo Clinic, 		G	
1	21502966	interferon beta-1a	L03AB07	efficacy	IFN-beta antibody development			N/A		G	
1	21659360	ANTINEOPLASTIC AGENTS	L01	efficacy	survival		fludarabine, chlorambucil, fludarabine with cyclophosphamide	CLL-4		G	
1	21764829	hepatitis B, purified antigen	J07BC01	efficacy	post-vaccination antibody titer			N/A		G	
1	21810746	nevirapine	J05AG01	side effects	drug-induced rash			N/A		G	
1	21844884	Platinum compounds, antineoplastic drugs	L01XA	efficacy	in vitro cytotoxicity	TRUE	cisplatin, carboplatin	N/A		G	
1	21990027	ANTIPSYCHOTICS	N05A	side effects	Extrapyramidal symptoms			STEP-BD		G	
1	22020760	oxaliplatin	L01XA03	side effects	peripheral neuropathy			N/A		G	
1	22041458	ANTIDEPRESSANTS	N06A	side effects	Outcomes included four indicators of side-effects: general side-effect burden, sexual side-effects, dizziness and vision/hearing-related side-effects		sertraline, venlafaxine, ciatlopram, bupropion, buspirone (anti-anxiety)	STAR*D		G	
1	22142827	gemcitabine	L01BC05	efficacy	survival		gemcitabine, bevacizumab (optional)	CALGB, PGRN-RIKEN		G	
1	22180457	tamoxifen	L02BA01	efficacy	survival			N/A		G	
1	22228203	fenofibrate	C10AB05	efficacy	inflammation related biomarkers			GOLDN		G	
1	22291609	fenofibrate	C10AB05	efficacy	inflammation related biomarkers			N/A		G	
1	22293537	gemcitabine	L01BC05	side effects	drug-induced agranulocytosis			Biobank Japan		G	
1	22331829	rosuvastatin	C10AA07	efficacy	LDL cholesterol			JUPITER		G	
1	22368281	atorvastatin	C10AA05	efficacy	LDL cholesterol			CARDS, ASCOT, PROSPER		G	
1	22379998	ANTIEPILEPTICS	N03	side effects	cutaneous adverse drug reactions		lamotrigine, phenytoin	EPIGEN		G	
1	22538805	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	forced expiratory volume			SHARP, CAMP, CARE, ACRN		Y	
1	22542470	smallpox, live attenuated	J07BX01	efficacy	antibody levels			N/A		G	
1	22566498	candesartan	C09CA06	efficacy	blood pressure			GERA		G	
1	22569225	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score, European League Against Rheumatism			DANBIO		G	
1	22584459	ANTIDEPRESSANTS	N06A	efficacy	Hamilton Rating Scale for Depression		paroxetine, fluvoxamine, nortriptyline, milnacipran	N/A		G	
1	22610502	smallpox, live attenuated	J07BX01	side effects	cytokine response			N/A		G	
1	22658931	anthrax antigen	J07AC01	efficacy	antibody levels			AVA000		G	
1	22664479	irinotecan	L01XX19	side effects	drug-induced agranulocytosis, diahrrea			N/A		G	
1	22666496	pravastatin	C10AA03	efficacy	reduction in CHD events			CARE, WOSCOPS, PROSPER, PHASE		G	
1	22760553	citalopram	N06AB04	side effects	PRISE: general side effect burden, overall tolerability, sexual side effects, dizziness and vision/hearing side effects			STAR*D		G	
1	22792082	salbutamol	R03AC02	efficacy	forced expiratory volume			CAMP, LOCCS, LODO, ACRN, SHARe, SHARP, PGRN-RIKEN		G	
1	22864933	capecitabine	L01BC06	efficacy	in vitro cytotoxicity	TRUE		N/A		G	
1	22872573	Platinum compounds, antineoplastic drugs	L01XA	efficacy	survival			N/A		G	
1	22890011	fenofibrate	C10AB05	efficacy	VLDL and HDL levels			GOLDN		G	
1	22907730	Selective serotonin reuptake inhibitors	N06AB	efficacy	QIDS-SR (Quick Inventory of Depressive Symptomatology, Self-Reported version)			PGRN-AMPS, PGRN-RIKEN		G	
1	22968431	multiple	N/A	side effects	drug-induced liver injury		multiple varied drugs	DILIN, DILIGEN, EUDRAGENE, DILI		G	
1	23006423	Taxanes, antineoplastic	L01CD	efficacy	survival		paclitaxel, docetaxel	N/A		G	
1	23047291	temozolomide	L01AX03	efficacy	in vitro cytotoxicity	TRUE		N/A		G	
1	23149075	fenofibrate	C10AB05	biomarker	circulating adiponectin			GOLDN		G	
1	23151678	tamsulosin	G04CA02	efficacy	tamsulosin hydrochloride concentration			N/A		G	
1	23183491	fentanyl	N01AH01	efficacy	dose			N/A		G	
1	23233662	methotrexate	L01BA01	efficacy	methotrexate clearance			N/A		G	
1	23241943	ANTIPSYCHOTICS	N05A	efficacy	illness severity		perphenazine, olanzapine, risperidone, quetiapine, clozapine, ziprazidone	CATIE		G	
1	23374588	Anticholinesterase anti-dementia drugs	N06DA	efficacy	illness severity		donepezil, galatamine, rivastigmine	N/A		G	
1	23400010	hydrochlorothiazide	C03AA03	biomarker	glucose and triglyceride levels			PEAR, GERA		G	
3	23459443	Sulfonylureas for blood glucose lowering	A10BB	side effects	QTc interval prolongation			Rotterdam, FHS, AGES, ARCS, CHS	Many different QT interval affecting drugs were tested	G	
3	23459443	Thiazides, plain	C03AA	side effects	QTc interval prolongation			Rotterdam, FHS, AGES, ARCS, CHS	Many different QT interval affecting drugs were tested	G	
3	23459443	Non-selective monoamine reuptake inhibitors	N06AA	side effects	QTc interval prolongation			Rotterdam, FHS, AGES, ARCS, CHS	Many different QT interval affecting drugs were tested	G	
1	23467860	dabigatran etexilate	B01AE07	efficacy	drug concentraion			RE-LY		G	
1	23478653	irinotecan	L01XX19	efficacy	survival		irinotecan, cisplatin	N/A		G	
1	23508266	salbutamol	R03AC02	efficacy	forced expiratory volume			CAMP, CARE, ACRN, GACRS, AT, LOCCS, LODO		G	
1	23555300	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score		etanercept, infliximab, adalimumab	ABCoN, GENRA, BeSt, BRAGGSS, BRASS, EIRA, eRA, KI, LUMC, TEAR, DREAM, GARNET		G	
1	23648065	ANTINEOPLASTIC AGENTS	L01	side effects	drug-induced agranulocytosis		cyclophosphamide‐ and platinum‐based (cisplatin and carboplatin), anthracycline‐based (doxorubicin and epirubicin), and antimetabolite‐based (5‐fluorouracil and gemcitabine) treatment, antimicrotubule agents (paclitaxel and docetaxel), and topoisomerase inhibitors (camptothecin and etoposide), as well as combination therapy with paclitaxel and carboplatin	Biobank Japan		G	
1	23726668	citalopram	N06AB04	efficacy	sustained clinical response			STAR*D		G	
1	23753411	hydrochlorothiazide	C03AA03	efficacy	blood pressure			PEAR, GERA, GENRES, NORDIL		G	
1	23755828	warfarin	B01AA03	efficacy	maintenance dose			IWPC, PGRN-RIKEN		G	
1	23776197	paclitaxel	L01CD01	side effects	peripheral neuropathy			N/A		G	
1	24009623	Selective immunosuppressants	L04AA	efficacy	in vitro cytotoxicity	TRUE	everolimus, sirolimus	N/A		G	
1	24025145	ANTINEOPLASTIC AGENTS	L01	side effects	drug-induced alopecia		5' fluorouracil, cyclophosphamide, epirubicin, doxorubicin, paclitaxel, docetaxel, antimicrotubule agents	Biobank Japan		G	
1	24143882	OPIOID ANALGESICS	N02A	side effects	opioid dependence			N/A		G	
1	24236485	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	M01A	side effects	Acute urticaria/angioedema			RIRAAF		G	
1	24280104	budesonide	R03BA02	efficacy	forced expiratory volume			CAMP, LOCCS, PGRN-RIKEN		G	
1	24282030	hepatitis B, purified antigen	J07BC01	efficacy	antibody levels			N/A		G	
1	24483146	Pyrimidine analogues, antineoplastic antimetabolites	L01BC	efficacy	in vitro IC50	TRUE	gemcitabine, cytarabine	N/A		G	
1	24486069	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	symptom frequency			CAMP, CARE, ACRN, LOCCS, PGRN-RIKEN		G	
1	24503447	Protease inhibitors, direct acting antivirals	J05AE	side effects	bilirubin levels		GS-9256	N/A		G	
1	24528284	Selective serotonin reuptake inhibitors	N06AB	efficacy	plasma drug concentraion		citalopram, escitalopram	PGRN-AMPS, PGRN-RIKEN		G	
1	24554482	Nucleoside and nucleotide reverse transcriptase inhibitors	J05AF	side effects	neuropathy		stavudine, didanosine	N/A		G	
1	24583629	methotrexate	L01BA01	efficacy	Disease Activity Score			AIIMS		G	
1	24709693	methotrexate	L01BA01	efficacy	(ACR-pedi) improvement criteria			SPARKS-CHARM, CHARMS-JIA		G	
1	24751813	haloperidol	N05AD01	efficacy	Positive and Negative Symptom Scale			CATIE		G	
1	24792382	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	forced expiratory volume			N/A		G	
1	24811271	measles, combinations with mumps and rubella, live attenuated	J07BD52	efficacy	cellular immune response			N/A		G	
1	24909733	morphine	N02AA01	efficacy	postoperative pain scores			N/A		G	
1	25089948	simvastatin	C10AA01	biomarker	PCSK9 levels			CAP		G	
1	25108385	azathioprine	L04AX01	side effects	drug-induced agranulocytosis		azathiopurine, mercaptopurine	N/A		G	
1	25117820	bevacizumab	L01XC07	side effects	hypertension			ECOG		G	
1	25187353	clozapine	N05AH02	side effects	drug-induced agranulocytosis			CIAC		G	
1	25214527	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	side effects	serum creatine kinase levels			MHI		G	
1	25217962	azathioprine	L04AX01	side effects	pancreatitis		azathiopurine, mercaptopurine	N/A		G	
1	25350695	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	LDL cholesterol			PROSPER, ASCOT, CARDS, PARC, TNT, AGES, BioVU, CHS, HVH, FHS, GoDARTS, HABC, MESA, Rotterdam, JUPITER		G	
1	25461247	DIRECT ACTING ANTIVIRALS	J05A	efficacy	virologic response		efavirenz, abacavir	ACTG		G	
1	25562107	Selective beta-2-adrenoreceptor agonist inhalants	R03AC	efficacy	forced expiratory volume			CAMP, CARE, ACRN		G	
1	25583994	dalcetrapib	N/A	efficacy	composite of cardiovascular events			N/A	Not approved	G	
1	25601762	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	forced expiratory volume			DICE		G	
1	25628645	omacetaxine mepesuccinate	L01XX40	efficacy	in vitro cytotoxicity	TRUE		N/A		G	
1	25649181	Selective serotonin reuptake inhibitors	N06AB	efficacy	CES-D			Rotterdam		Y	
1	25656473	clozapine	N05AH02	side effects	in vitro cytotoxicity	TRUE		N/A		G	
1	25672763	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	M01A	side effects	Stevens-Johnson syndrome			N/A		G	
1	25676789	allopurinol	M04AA01	efficacy	serum uric acid			GERA, RPGEH		G	
1	25710658	vincristine	L01CA02	side effects	peripheral neuropathy			SJCRH		G	
1	25813999	triamcinolone	A01AC01	side effects	ocular hypertension			Florida-1, Florida-2		G	
1	25823687	Platinum compounds, antineoplastic drugs	L01XA	side effects	myelosuppression			N/A		G	
1	25897834	Selective serotonin reuptake inhibitors	N06AB	efficacy	Hamilton Rating Scale for Depression			PGRN-AMPS, STAR*D, PGRN-RIKEN		G	
1	25935875	ticagrelor	B01AC24	efficacy	ticagrelor levels			PLATO		G	
3	25944848	ANTIEPILEPTICS	N03	efficacy	concentration dose ratio			TOP	looked at CDR for three drug classes	G	
3	25944848	ANTIPSYCHOTICS	N05A	efficacy	concentration dose ratio			TOP	looked at CDR for three drug classes	G	
3	25944848	ANTIDEPRESSANTS	N06A	efficacy	concentration dose ratio			TOP	looked at CDR for three drug classes	G	
1	25964295	HORMONE ANTAGONISTS AND RELATED AGENTS	L02B	efficacy	survival			HEBCS, POSH, SUCCESS-A		G	
1	25987243	lapatinib	L01XE07	side effects	drug-induced liver injury			TEACH		G	
1	25987655	asparaginase	L01XX02	side effects	Hypersensitivity reaction			SJCRH		G	
1	26015512	paclitaxel	L01CD01	side effects	peripheral neuropathy, in vitro cytotoxicity	TRUE		Biobank Japan, PGRN-RIKEN		G	
1	26025128	prednisone	H02AB07	side effects	bone mineral accretion			CAMP		G	
1	26030142	vancomycin	A07AA09	biomarker	serum creatinine levels			BioVU		G	
1	26031901	Leukotriene receptor antagonists for obstructive airway diseases	R03DC	efficacy	forced expiratory volume		zileuton	LOCCS, LODO, ALA-ACRC, PGRN-RIKEN		G	
1	26083242	Montelukast	R03DC03	efficacy	forced expiratory volume			ALA-ACRC, LOCCS, LODO, CARE, CLIC, PACT, PGRN-RIKEN		G	
1	26121980	triptolide	N/A	efficacy	in vitro cytoxicity	TRUE		N/A		G	
1	26148204	tenofovir disoproxil	J05AF07	biomarker	tenofovir clearance			ACTG		G	
1	26151496	Thiouracil antithyroid preparations	H03BA	side effects	drug-induced agranulocytosis			N/A		G	
1	26169577	ACE inhibitors, plain	C09A	side effects	drug-induced cough			eMERGE, GoDARTS		G	
1	26220383	lamotrigine	N03AX09	side effects	lamotrigine-induced skin rash			KARE		G	
1	26222057	cetuximab	L01XC06	efficacy	survival			CAIRO2, DCCG		G	
1	26237429	Anthracyclines and related substances	L01DB	side effects	drug-induced cardiotoxicity			N/A		G	
1	26265036	warfarin	B01AA03	efficacy	maintenance dose			N/A		G	
1	26265699	Glucocorticoids, Systemic	H02AB	side effects	osteonecrosis			SJCRH, BioVU		G	
1	26323598	antipsychotics	N05A	side effects	drug-induced weight gain			CATIE		Y	
1	26348319	Selective serotonin reuptake inhibitors	N06AB	efficacy	Hamilton Rating Scale for Depression			N/A		G	
1	26407342	nicotine	N07BA01	efficacy	nicotine metabolite ratio			FinnTwin12, FinnTwin16, YFS, FINRISK, NAG-FIN		G	
1	26460308	Monoclonal antibodies, antineoplastic	L01XC	efficacy	survival			LYSA, Mayo, SPORE, GOELAMS, 		G	
1	26503763	lithium	N05AN01	efficacy	subjective and objective measures of efficacy			BipoläR, St Göran Bipolar Project, BDRN, WTCCC2, WTCCC		G	
1	26503814	salbutamol	R03AC02	efficacy	forced expiratory volume			COPDGene, ECLIPSE, GenKOLS, NETT		G	
4	26516778	Thiazides, plain	C03AA	side effects	cardiovascular disease incidence			CHARGE, AGES, ARIC, CHS, FHS, Health ABC, HVH, MESA, PROSPER, RS	four gwas in this study	G	
4	26516778	BETA BLOCKING AGENTS	C07A	side effects	cardiovascular disease incidence			CHARGE, AGES, ARIC, CHS, FHS, Health ABC, HVH, MESA, PROSPER, RS	four gwas in this study	G	
4	26516778	CALCIUM CHANNEL BLOCKERS	C08	side effects	cardiovascular disease incidence			CHARGE, AGES, ARIC, CHS, FHS, Health ABC, HVH, MESA, PROSPER, RS	four gwas in this study	G	
4	26516778	ACE inhibitors, plain	C09A	side effects	cardiovascular disease incidence			CHARGE	four gwas in this study	G	
1	26546620	pazopanib	L01XE11	side effects	drug-associated liver injury			N/A		G	
1	26566055	fentanyl	N01AH01	efficacy	postoperative opioid requirements			N/A		G	
1	26599303	carbimazole	H03BB01	side effects	drug-induced agranulocytosis			N/A		G	
1	26634245	salbutamol	R03AC02	efficacy	forced expiratory volume			COPDGene		G	
1	26644207	interferon beta-1a	L03AB07	efficacy	recovery from multiple sclerosis			N/A		G	
1	26776603	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score			N/A		G	
1	26806518	lithium	N05AN01	efficacy	Alda scale			ConLiGen		G	
1	26838040	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	biomarker	creatinine kinase			N/A		G	
1	26856250	risperidone	N05AX08	efficacy	Positive and Negative Syndrome Scale			CATIE		G	
1	26876947	clozapine	N05AH02	side effects	drug-induced agranulocytosis			N/A		G	
1	26959717	flupirtine	N02BG07	side effects	drug-induced liver injury			iDILIC		G	
1	26980576	cyclophosphamide	L01AA01	efficacy	lupus nephritis			N/A		G	
1	27002377	fenofibrate	C10AB05	efficacy	lipid response			GOLDN, ACCORD		G	
2	27047539	paclitaxel	L01CD01	efficacy	in vitro IC50	TRUE		N/A		G	
2	27047539	carboplatin	L01XA02	efficacy	in vitro IC50	TRUE		N/A		G	
1	27143689	docetaxel	L01CD02	side effects	peripheral neuropathy			CALGB, PGRN-RIKEN		G	
1	27157822	Sulfur-containing imidazole derivatives, antithyroid preparations	H03BB	side effects	drug-induced agranulocytosis		thiamazole [methimazole], carbimazole, or propylthiouracil	EuDAC		G	
1	27400856	clozapine	N05AH02	side effects	drug-induced agranulocytosis			CLOZUK, CardiffCOGS, CIAC		G	
1	27500523	metformin	A10BA02	efficacy	HbA1c levels			ACCORD, DCS, GoDARTS, RIGA, Rotterdam, Kosice, UKPDS, Sarajevo, PMT1-EU, PMT2-EU, PMT1-AF, PMT2-AF, PMT2-AS, PMT2-LA, SAPPHIRE, DPP, HOME, RPEGH, WTCCC2, GERA, PMT, WTCCC, PGRN-RIKEN		G	
1	27558924	azathioprine	L04AX01	side effects	drug-induced agranulocytosis			N/A		G	
1	27564568	mercaptopurine	L01BB02	efficacy	erythrocyte TPMT activity			SJCRH		G	
1	27587472	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	HDL-C levels			ASCOT UK, CARDS, CAP, PRINCE, PROSPER, TNT, AGES, ARIC, ASCOT UK-observational, BioVU, CHS, FHS, Health ABC, HVH, MESA, Rotterdam		G	
3	27622933	selective serotonin reuptake inhibitors	N06AB	efficacy	self reported efficacy			23andMe	This 23andMe study looked at 4 groups of antidepressants for responders and nonresopnders.  Some don't fit nicely into drug classes and would contradict the way i've been doing things	G	
3	27622933	citalopram	N06AB04	efficacy	self reported efficacy			23andMe	This 23andMe study looked at 4 groups of antidepressants for responders and nonresopnders.  Some don't fit nicely into drug classes and would contradict the way i've been doing things	G	
3	27622933	bupropion	N06AX12	efficacy	self reported efficacy		bupropion	23andMe	This 23andMe study looked at 4 groups of antidepressants for responders and nonresopnders.  Some don't fit nicely into drug classes and would contradict the way i've been doing things	G	
2	27670767	BETA BLOCKING AGENTS	C07A	side effects	drug-induced diabetes			INVEST, INVEST-GENES, PGRN-RIKEN		G	
2	27670767	calcium channel blockers	C08	side effects	drug-induced diabetes			INVEST, INVEST-GENES, PGRN-RIKEN		G	
1	27671213	rifampicin	J04AB02	side effects	drug-induced liver injury			N/A		G	
1	27702941	caffeine	N06BC01	metabolism	plasma drug concentraion			UK Biobank		G	
1	27723809	peginterferon alfa-2a	L03AB11	side effects	drug-induced depression			N/A	peginterferon alfa-2a + ribavirin	G	
1	27758888	Aromatase inhibitors	L02BG	efficacy	breast cancer reoccurence		anastrozole, exemestane	N/A, PGRN-RIKEN		G	
1	27802415	hydrochlorothiazide	C03AA03	efficacy	blood pressure			International Consortium for Antihypertensive Pharmacogenomics Studies		G	
1	27846195	paliperidone	N05AX13	efficacy	Clinical Global Impression Scale-Severity			N/A		G	
1	27958378	Sulfonylureas for blood glucose lowering	A10BB	side effects	ECG phenotypes: QT, JT, and QRS intervals			CHARGE, AGES, ARIC, CHS, Health ABC, HCHS/SOL, JHS, MESA, NEO, PROSPER, Rotterdam, WHI		G	
1	28030426	ACE inhibitors, plain	C09A	efficacy/side effects	Drug switching			Rotterdam, GoDARTS	This study looked for drug switching within two years.  Could be a result of both efficacy and side effects	G	
1	28039263	cisplatin	L01XA01	side effects	drug-induced ototoxicity, quantitative audiometry			Platinum Study, PGRN-RIKEN		G	
1	28039329	Non-selective monoamine reuptake inhibitors	N06AA	side effects	ECG phenotypes: QT, RR intervals			CHARGE, AGES, ARIC, ASCOT, CHS, FHS, Health ABC, JHS, MESA, NEO, PROSPER, Rotterdam, SOL, WHI, WHIMS	CHARGE is a consortium of studies. This study does not list the specific studies included from CHARGE	G	
2	28043905	terbinafine	D01AE15	side effects	drug-induced liver injury			DILIN, DILIGEN, EUDRAGENE, iDILIC	This one is annoying.  They do a mixed drug group for any liver injury.  Then they do single drugs.  But the single drugs have like 5-20 cases.  Terbinafine has a very significant peak in HLA, but only 14 cases.  I don't really want to count these.	G	
2	28043905	multiple	N/A	side effects	drug-induced liver injury			DILIN, DILIGEN, EUDRAGENE, iDILIC	This one is annoying.  They do a mixed drug group for any liver injury.  Then they do single drugs.  But the single drugs have like 5-20 cases.  Terbinafine has a very significant peak in HLA, but only 14 cases.  I don't really want to count these.	G	
1	28062682	nevirapine	J05AG01	side effects	nevirapine hypersensitivity: NIR (wedespread maculopapular exanthema), HSS (widespread rash with systemic manifestations), SJS, TEN, drug-induced liver injury			N/A		G	
1	28084903	ACE inhibitors, plain	C09A	side effects	drug-induced cough			SWEDEGENE		G	
1	28090653	ANTINEOPLASTIC AGENTS	L01	biomarker	alanine aminotransferase		asparaginase, prednisone, vincristine, daunorubicin, cyclophosphamide, cytarabine, thiopurine	SJCRH	This study looked for genome-wide associations with altered alanine aminotransferase levels in response to combination chemotherapy.  This biomarker may be an indicator for liver damage.	G	
1	28100913	COUGH AND COLD PREPARATIONS	R05	side effects	Stevens-Johnson syndrome			N/A		Y	
1	28120872	cisplatin	L01XA01	efficacy	survival		cisplatin	N/A		Y	
1	28163062	interferon	S01AD05	side effects	development of hepatocellular carcinoma		interferon	Japanese Genome-Wide Association Study Group for Viral Hepatitis		Y	
1	28173075	metformin	A10BA02	efficacy	in vitro cytotoxicity	TRUE	metformin	N/A		Y	
1	28207573	clopidogrel	B01AC04	efficacy	clopidogrel active metabolie levels		clopidogrel	PAPI		G	
1	28222112	ANTIHYPERTENSIVES	C02	efficacy	resistance to hypertension (elevated blood pressure)			eMERGE		Y	
1	28289848	measles immunoglobulin	J06BB14	efficacy	measles specific neutralizing antibody			N/A		G	
1	28317148	bortezomib	L01XX32	side effects	peripheral neuropathy		bortezomib	N/A		Y	
2	28388302	rifampicin	J04AB02	side effects	drug-induced liver injury		rifampicin	N/A		Y	
2	28388302	efavirenz	J05AG03	side effects	drug-induced liver injury		efavirenz	N/A		Y	
1	28437668	venlafaxine	N06AX16	efficacy	HAM-A, CGI			N/A		Y	
1	28500057	methotrexate	L01BA01	side effects	methotrexate pneumonitis		methotrexate	Pneumonitis Study Consortium		Y	
1	28542097	Anthracyclines and related substances	L01DB	side effects	left ventricular function			BioVU, PREDICT		Y	
1	28686080	warfarin	B01AA03	efficacy	maintenance dose		warfarin	N/A		Y	
1	28696415	duloxetine	N06AX21	efficacy	percentage change in Montgomery-Åsberg Depression Rating Scale score from baseline			N/A		Y	
1	28736931	fenofibrate	C10AB05	efficacy	lipid response		fenofibrate	ACCORD		Y	
1	28753643	LIPID MODIFYING AGENTS, PLAIN	C10A	efficacy	major coronary events and myocardial infarction		darapladib	STABILITY, SOLID-TIMI 52		Y	
1	28762467	sulfasalazine	A07EC01	side effects	drug-induced agranulocytosis		sulfasalazine	EuDAC		Y	
1	28763429	ANTINEOPLASTIC AGENTS	L01	side effects	cardiotoxicity		paclitaxel, trastuzumab	N/A		Y	
1	28921760	nicotine	N07BA01	side effects	nicotine metabolite ratio		nicotine	PNAT2, KIS3, KIS2		Y	
1	28935272	ANTINEOPLASTIC AGENTS	L01	efficacy	survival		paclitaxel, cisplatin, carboplatin	GOG 172, GOG 182		Y	
1	29064910	ANTIPSYCHOTICS	N05A	side effects	arrhythmias		ANTIPSYCHOTICS	CATIE		Y	
2	29097388	Thiazides, plain	C03AA	side effects	uncontrolled BP		combination therapy	PEAR, INVEST, PGRN-RIKEN	combination therapy 	Y	
2	29097388	beta-Adrenergic Blocking Agents	C07	side effects	uncontrolled BP		combination therapy	PEAR, INVEST, PGRN-RIKEN	combination therapy 	Y	
1	29121268	lithium	N05AN01	efficacy	ALDA scale		lithium	ConLiGen		Y	
1	29160300	tacrolimus	L04AD02	efficacy	tacrolimus trough concentration		tacrolimus	DeKAF		Y	
1	29160301	ANTIDEPRESSANTS	N06A	efficacy	symptom improvement and remission		antidepressants	STAR*D		Y	
1	29207912	Morphinan derivatives, opiod analgesics	N02AF	efficacy	pain		opioids	N/A	in colectomy patients	Y	
1	29229094	mepolizumab	R03DX09	efficacy	clinically significant exacerbation rate		mepolizumab	MENSA, DREAM		Y	
1	29253144	measles, combinations with mumps and rubella, live attenuated	J07BD52	efficacy	Rubella Virus-Specific Cellular Immunity		MMR vaccine	N/A		Y	
1	29266176	ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS	D06C	side effects	bone mineral density (BMD)			SJCRH		Y	
1	29278617	Taxanes, antineoplastic	L01CD	side effects	peripheral neuropathy		taxane	North American Breast Cancer Intergroup clinical trial		Y	
1	29288229	ANTIEPILEPTICS	N03A	side effects	maculopapular exanthema		phenytoin	ILAE-CGC, EpiPGX, EPIGEN		Y	
1	29315502	atazanavir	J05AE08	efficacy	concentration in hair			WIHS		Y	
1	29367611	ANTINEOPLASTIC AGENTS	L01	efficacy	blood concentration		paclitaxel, carboplatin	N/A		Y	
1	29423119	Natural and semisynthetic estrogens, plain	G03CA	efficacy	survival			HEBCS, POSH, SUCCESS-A		Y	
1	29478026	beta-Adrenergic Blocking Agents	C07	efficacy	heart rate			PEAR, PEAR-2		Y	
1	29503163	ANTIPSYCHOTICS	N05A	efficacy	Positive and Negative Syndrome Scale		olanzapine, risperidone, quetiapine, aripiprazole, ziprasidone, haloperidol, perphenazine	Chinese Antipsychotics Pharmacogenomics Consortium		G	
1	29521573	interferon beta-1a	L03AB07	efficacy	neutralizing antibodies			BEtaseron, BEtaferon, BENEFIT, BEYOND		Y	
1	29523524	Thiazides, plain	C03AA	side effects	glucose levels			PEAR, PEAR-2		Y	
1	29534301	Hepatitis vaccines	J07BC	efficacy	HBsAb levels			N/A		Y	
1	29551627	Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics	R03AK	side effects	adrenal suppression		inhaled corticosteroids	WTCCC2, PASS, PASIC		Y	
1	29559929	Selective serotonin reuptake inhibitors	N06AB	efficacy	Hamilton Rating Scale for Depression, QIDS-C16			PGRN-AMPS, ISPC, PGRN-RIKEN		Y	
1	29650774	metformin	A10BA02	efficacy	HbA1c levels			MetGen Consortia, ACCORD, PGRN-RIKEN		Y	
1	29730043	lurasidone	N05AE05	efficacy	Positive and Negative Syndrome Scale		lurasidone	PEARL 1, PEARL 2, PEARL 3		Y	
1	29923122	Selective immunosuppressants	L04AA	side effects	adverse events that triggered a modification in the usage of a drug or its discontinuation		thiopurine	MENDEL		Y	
1	29934777	heparin	B01AB01	side effects	drug-induced thrombocytopenia			N/A		Y	
1	29998114	ANTIDEPRESSANTS	N06A	efficacy	QIDS-SR			CO-MED		Y	
1	30013178	interferon beta-1a	L03AB07	side effects	drug-induced liver injury		interferon beta-1a	SWEDEGENE, DILIN		Y	
1	30034349	Selective serotonin reuptake inhibitors	N06AB	efficacy	Hamilton Rating Scale for Depression			TVGH		Y	
1	30054556	ranibizumab	S01LA04	efficacy	visual acuity			N/A		Y	
1	30067105	carbimazole	H03BB01	side effects	drug-induced liver injury		carbimazole	N/A		Y	
1	30161160	tamoxifen	L02BA01	efficacy	Ki-67 response			N/A		G	
1	30166627	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score			BRAGGSS, MATURA Consortium		Y	
1	30201983	mercaptopurine	L01BB02	efficacy	concentrations			N/A		Y	
1	30237584	ANTIHYPERTENSIVES	C02	efficacy	blood pressure			eMERGE, PGRN-RIKEN		Y	
1	30255771	fenofibrate	C10AB05	efficacy	triglyceride levels 			GOLDN		Y	
2	30263045	fenofibrate	C10AB05	efficacy	HDL-C levels			GOLDN		Y	
2	30263045	fenofibrate	C10AB05	efficacy	triglyceride levels 		fenofibrate	GOLDN		Y	
1	30277654	Morphinan derivatives, opiod analgesics	N02AF	efficacy	numerically rated pain intensity			N/A		Y	
1	30353303	oxygen	V03AN01	efficacy	death or hospitalization		oxygen	LOTT, COPDGene		Y	
1	30357299	warfarin	B01AA03	side effects	drug-induced bleeding		warfarin	IWPC		Y	
1	30367910	Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics	R03AK	efficacy	asthma control test (ACT)		inhaled corticosteroids	SAPPHIRE, GALA II, SAGE II		Y	
1	30371334	VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12	A11D	efficacy	blood lipid levels		niacin	AIM-HIGH	statin + niacin combination therapy	Y	
1	30377885	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	M01A	side effects	drug-induced enteropathy			N/A		Y	
1	30450575	Asparaginase	L01XX02	side effects	Hypersensitivity reaction using Common Terminiology Criteria for Adverse Events		PEG-Asparaginase	NOPHO		Y	
1	30468137	ANTIDEPRESSANTS	N06A	efficacy	QIDS-C16			STAR*D, GSRD, GENDEP		Y	
1	30552317	ketamine	N01AX03	efficacy	HAM-D,  MADRS, CADSS		ketamine	N/A		Y	
1	30557370	cetuximab	L01XC06	side effects	severe skin toxicity, NCI Common Toxicity Criteria		cetuximab	CAIRO2		Y	
1	30647433	clozapine	N05AH02	side effects	drug-induced agranulocytosis		clozapine	CLOZUK2	African population	Y	
1	30648747	Anastrozole	L02BG03	efficacy	plasma drug concentraion		Anastrozole	N/A, PGRN-RIKEN		Y	
1	30697902	Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics	R03AK	efficacy	forced expiratory volume		inhaled corticosteroids	PiCa, GALA II, SAGE, PACMAN, BREATHE, SLOVENIA, ESTATEe		Y	
1	30700811	ANTIDEPRESSANTS	N06A	efficacy	antidepressant treatment resistance			GENDEP, GS:SFHS	inferring antidepressant switching as non-response to treatment	Y	
1	30715261	interferon	S01AD05	efficacy	HBeAg loss		interferon	GIANT-B Global Consortium		Y	
1	30801552	tacrolimus	L04AD02	efficacy	tacrolimus trough concentration		tacrolimus	DeKAF Genomics and GEN-03 Investigators		Y	
1	30806694	Selective immunosuppressants	L04AA	side effects	myelosuppression		thiopurine	IBD Pharmacogenetics Study Group		Y	
1	30868120	Carboxamide derivatives, antiepileptics	N03AF	side effects	hyponatremia		carbamazepine or oxcarbazepine	EpiPGx		Y	
1	30889042	gemcitabine	L01BC05	side effects	drug-induced agranulocytosis		gemcitabine	CALGB, PGRN-RIKEN		Y	
1	30922102	clozapine	N05AH02	efficacy	plasma drug concentraion		clozapine	CLOZUK2		Y	
1	30924126	allopurinol	M04AA01	efficacy	change in serum uric acid levels		allopurinol	Kaiser Permanente Research Program, GERA, BioVU, PGPop, MARSH, PGRN, PGRN-RIKEN		Y	
1	30952644	cisplatin	L01XA01	side effects	drug-induced tinnitus			The Platinum Study		Y	
1	30972912	peginterferon alfa-2a	L03AB11	efficacy	hepatitis antigen seroconversion or clearance			PEG-BE-YOND		Y	
1	31006051	Bisphosphonate drugs affecting bone structure and mineralization	M05BA	side effects	Atypical femoral fracture			N/A		Y	
1	31039275	infliximab	L04AB02	efficacy	Mucosal healing		infliximab	N/A		Y	
1	31043678	adalimumab	L04AB04	efficacy	Antibody production after therapy		adalimumab	IMIDC		Y	
1	31066027	carbamazepine	N03AF01	side effects	Hypersensitivity reaction		carbamazepine	WTCCC, ITCH, POPRES, Spanish Bladder Cohort, Hypergenes cohort, National Spanish DNA Bank, Swedish Twin Registry, IPTC, iDILIC, DILIN	metanalysis	Y	
1	31109976	rifampicin	J04AB02	side effects	Antituberculosis drug-induced liver injury		rifampicin	N/A		Y	
1	31189108	haemophilus influenzae B and poliomyelitis	J07CA04	efficacy	persistence of immunity			N/A		Y	
1	31220337	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	side effects	statin-induced myopathy		atorvastatin	WTCCC, UKMYONET, CPRD, EUDRAGENE		Y	
1	31243853	Hepatitis vaccines	J07BC	efficacy	anti-HBs levels		Hep B vaccine	N/A		Y	
2	31260374	ANTIVIRALS FOR SYSTEMIC USE	J05	efficacy	sustained virologic response (SVR) and viremia			BOSON, HCVRUK	combination therapy	Y	
2	31260374	interferon	S01AD05	efficacy	sustained virologic response (SVR) and viremia			BOSON, HCVRUK	combination therapy	Y	
1	31296530	cisplatin	L01XA01	side effects	serum platinum residuals (lab values)		cisplatin	The Platinum Study	used lab values with time-adjusted model	Y	
1	31299468	salmeterol	R03AC12	efficacy	forced expiratory volume, St George's Respiratory Questionnaire (SGRQ)			N/A	made a point to mention we did more than FEV	Y	
1	31371054	ANTINEOPLASTIC AGENTS	L01	side effects	amenorrhea			SUCCESS		Y	
1	31407531	ANTIHYPERTENSIVES	C02	efficacy	left ventricular mass and relative wall thickness			CARDIA, CHS, JHS, GENOA, HyperGEN		Y	
1	31423876	beta-Adrenergic Blocking Agents	C07	efficacy	blood pressure			PEAR, PEAR-2, LIFE-Fin, GENRES, BB-SS, INVEST, ASCOT UK, ASCOT SC, 		Y	
1	31455332	phenylephrine	C01CA06	efficacy	infusion rates		phenylephrine	Geisinger, MyCode	interesting use of clinical data - did not measure response, but infusion rates	Y	
1	31465739	adalimumab	L04AB04	efficacy	presence of  Hidradenitis suppurativa		adalimumab	PIONEER I, PIONEER II		Y	
1	31545351	ANTIHYPERTENSIVES	C02	efficacy	blood pressure			CHARGE, EURAGEDIC, After-EU, AGES, HyperGEN, NEO, PROSPER, ARIC, CHS, FHS, HVH, JHS, MESA, MVP, 		Y	
1	31557306	budesonide	R03BA02	efficacy	coughing/wheezing, vital capacity		nedocromil/budesonide	CAMP		Y	
1	31597885	trastuzumab	L01XC03	side effects	drug-induced cardiotoxicity		trastuzumab	NCC Biobank		Y	
1	31748705	Angiotensin II receptor blockers (ARBs), other combinations	C09DX	side effects	uric acid levels		thiazide-like diuretic, indapamide, valsartan, amlodipine	GEANE		Y	
1	31749835	dimethyl fumarate	L04AX07	side effects	severe prolonged lymphopenia		dimethyl fumarate	DEFINE, CONFIRM		Y	
1	31754133	OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC	C09X	efficacy	blood lipid concentrations			PEAR, PEAR-2		Y	
1	31806883	Angiotensin II receptor blockers (ARBs), other combinations	C09DX	efficacy	blood lipid concentrations			AGES, ARIC, CHS, FHS, Health ABC, HVH1, HVH2, HyperGEN, MESA, PROSPER, RS1, RS2, WHI CT GARNET Baseline, WHI CT GARNET Core, JHS, WHI CT SHARe Baseline, WHI CT SHARe Core, WHI OS SHARe Baseline, WHI, Rotterdam		Y	
1	31841498	Vitamin D and analogues	A11CC	efficacy	serum concentration			VIDI		Y	
1	31969989	LIPID MODIFYING AGENTS, PLAIN	C10A	efficacy	low-density lipoprotein cholesterol lab values			GERA		Y	
1	32009195	mepolizumab	R03DX09	efficacy	accrued duration of remission, average oral glucocorticoid dose, and frequency of relapse		mepolizumab	MIRRA		Y	
1	32066683	clozapine	N05AH02	side effects	myocarditis		clozapine	N/A	this cohort is reused a bunch but not named anything	Y	
1	32080354	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM	C09	side effects	angioedema			N/A		Y	
1	32119686	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	occurrence of exacerbations		corticosteroid	CAMP, ACRN, CARE, PACT, CLIC, PGPop, PMRP, BioVU		Y	
1	32126890	amisulpride	N05AL05	side effects	drug-induced weight gain		amisulpride	OPTiMiSE cohort		Y	
1	32308125	Other antiepileptics in ATC	N03AX	efficacy	prevention of symptoms		lamotrigine, levetiracetam and valproic acid	EpiPGx		Y	
1	32355309	zonisamide	N03AX15	efficacy	"Off time" (time without parkinson's symptoms)		zonisamide	N/A		Y	
1	32376702	bezlotoxumab	J06BB21	efficacy	Recurrence-free efficacy		bezlotoxumab	MODIFY I, MODIFY II		Y	
1	32378780	Anthracyclines and related substances	L01DB	side effects	drug-induced cardiotoxicity		anthracycline	N/A		Y	
1	32433338	tafenoquine	P01BA07	efficacy	Recurrence-free efficacy		tafenoquine	GATHER, DETECTIVE		Y	
1	32438682	antineoplastic agent	L01	side effects	Symptomatic venous thromboembolism			NOPHO, ERASE		Y	
1	32472697	clopidogrel	B01AC04	side effects	adenosine diphosphate-induced platelet reactivity and major cardiovascular and cerebrovascular events		clopidogrel	ICPC, PGRN-RIKEN		Y	
1	32555152	clozapine	N05AH02	efficacy	CLZ serum concentration		clozapine	N/A		Y	
1	32558222	rhododendrol	N/A	side effects	RD‐induced leukoderma		rhododendrol	N/A		Y	
1	32562552	paclitaxel	L01C	side effects	peripheral neuropathy		paclitaxel	CALGB, UK Biobank, PGRN-RIKEN		Y	
1	32627186	Other antiepileptics in ATC	N03AX	efficacy	Alda scale		valproate, divalproex, lamotrigine, carbamazepine, oxcarbazepine	Mayo Clinic Bipolar Disorder Biobank		Y	
1	33012170	beta-Adrenergic Blocking Agents	C07	efficacy	survival		carvedilol, metoprolol, bisoprolol, atenolol, labetalol	HFPGR, TIME-CHF, HF-ACTION		Y	
1	32733355	levodopa	N04BA01	side effects	drug-induced dyskinesia		levodopa	N/A		G	
1	33138277	metamizole sodium	N02BB02	side effects	drug-induced agranulocytosis		metamizole	EuDAC		G	
1	22952603	dexamfetamine	N06BA02	other	subjective response questionairre			N/A		G	
1	29082582	ethanol	V03AB16	side effects	AUDIT			N/A	Alcohol abuse	G	
1	22491018	tocilizumab	L04AC07	efficacy	Disease Activity Score			RADIATE, OPTION, TOWARD, AMBITION, LITHE, MEASURE, European League Against Rheumatism		G	
1	21991891	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	forced expiratory volume			CAMP, SOCS/SLIC, Adult Study, LOCCS, CARE, PGRN-RIKEN		G	
1	23533358	OPIOID ANALGESICS	N02A	side effects	addiction			COGA, FSCD, COGEND		G	
1	22310353	drotrecogin alfa (activated)	B01AD10	efficacy	survival			PROWESS		G	
1	24165912	potassium chloride	A12BA01	efficacy	blood pressure		Dietary supplementation of potassium and high and low sodium diets	GenSalt		G	
1	25898129	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	LDL cholesterol			PARC, PRINCE		G	
1	20031582	atorvastatin	C10AA05	efficacy	blood lipid levels			TNT		G	
1	22823124	cannabinoids	N02BG10	other	cannabis use		Use initiation	N/A		G	
1	18521090	iloperidone	N05AX14	efficacy	Positive and Negative Syndrome Scale			N/A		G	
1	26811534	Anthracyclines and related substances	L01DB	side effects	drug-induced cardiomyopathy			COG		G	
1	27981573	clopidogrel	B01AC04	biomarker	PRU and H4 concentration			N/A		G	
1	23180272	Acetylsalicylic acid	N02BA01	side effects	drug-induced respiratory disease			N/A		G	
1	27669169	Protein kinase inhibitors, antineoplastic drugs	L01XE	efficacy	survival			GELAC, TALL, TNS, TFNS, TGFNS		G	
1	29382897	methylphenidate	N06BA04	efficacy	CGI-I			N/A		G	
1	26138065	Taxanes, antineoplastic	L01CD	side effects	drug-induced peripheral neuropathy			ECOG-5103		G	
1	27060151	bortezomib	L01XX32	side effects	drug-induced peripheral neuropathy			GMMG, HOVON-65		G	
1	25665007	cisplatin	L01XA01	side effects	hearing loss			SJRCH		G	
1	23838604	ACE inhibitors, plain	C09A	side effects	angioedema			ONTARGET, PGRN-RIKEN		G	
1	23594818	metamfetamine	N06BA03	side effects	drug-induced psychosis			N/A		G	
1	23508960	Acetylsalicylic acid	A01AD05	metabolism	aspirin hydrolysis			Cleveland Clinic GeneBank		G	
1	22437554	tocopherol	A11HA03	biomarker	circulating α-tocopherol concentration			ATBC		G	
1	27523435	fluticasone furoate	R01AD12	efficacy	forced expiratory volume			N/A		G	
1	21570397	amoxicillin and beta-lactamase inhibitor	J01CR02	efficacy	drug-induced liver injury			DILIGEN, Spanish DILI Registry, DILIN, EUDRAGENE		G	
1	22310351	fluorouracil	L01BC02	side effects	adverse reactions during treatment			EPICOLON II		G	
1	29580174	hydrochlorothiazide	C03AA03	biomarker	serum uric acid			GENRES< LIFE		G	
1	24223155	multiple	N/A	side effects	Torsades de Pointes			DARE, PGRN-RIKEN		G	
1	27023328	dabrafenib	L01XE23	side effects	pyrexia			BREAK-3		G	
1	20463552	Platinum compounds, antineoplastic drugs	L01XA	efficacy	Response Evaluation Criteria in Solid Tumors			N/A		G	
1	28835685	ranibizumab	S01LA04	efficacy	visual acuity			N/A		G	
1	21245432	lapatinib	L01XE07	side effects	drug-induced liver injury			N/A		G	
1	21961650	lithium	N05AN01	efficacy	11-point scale quantifying change in mood			N/A		G	
3	24192120	calcium channel blockers	C08	efficacy	blood pressure			HOMED-BP, GEANE		G	
3	24192120	Angiotensin II receptor blockers (ARBs), plain	C09C	efficacy	blood pressure			HOMED-BP, GEANE		G	
3	24192120	ACE inhibitors, plain	C09A	efficacy	blood pressure			HOMED-BP, GEANE		G	
1	25896534	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	EULAR			N/A		G	
1	26840454	ANTINEOPLASTIC AGENTS	L01	efficacy	survival		carboplatin and paclitaxel	OCAC, AOCS, MAYO, TCGA		G	
1	22417934	multiple	N/A	side effects	Multiple phenotypes measured.  Associations with BMI and HDL-C levels.		Many psychopharmacological treatments. Antidepressents, antipsychotics, mood stabalizers	TOP		G	
1	29703846	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	coronary heart disease			mMERGE, BioVU, BioVU-RIKEN, PGRN, PGRN-RIKEN		G	
1	23100282	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	efficacy	LDL cholesterol			Heart Protection Study		G	
1	26573232	ANTINEOPLASTIC AGENTS	L01	efficacy	pathologic complete response			N/A		G	
1	20639878	lumiracoxib	M01AH06	side effects	drug-induced liver injury			TARGET		G	
1	26100964	Platinum compounds, antineoplastic drugs	L01XA	side effects	drug-induced liver injury			N/A		G	
1	29293525	Glucagon-like peptide-1 (GLP-1) analogues	A10BJ	efficacy	insulin secretion			NTR		G	
1	25410890	losartan	C09CA01	efficacy	blood pressure			SOPHIA		G	
1	21826682	HMG CoA reductase inhibitors, plain lipid modifying drugs	C10AA	side effects	statin-induced myopathy			N/A		G	
1	25201287	hydrochlorothiazide	C03AA03	side effects	potassium response			PEAR, GERA		G	
1	28800628	sotalol	C07AA07	side effects	ventricular repolarization			GENEREPOL		G	
1	19448189	lithium	N05AN01	efficacy	Structured Clinical Interview			STEP-BD		G	
1	28783044	Thiazides, plain	C03AA	side effects	hyponatremia			N/A		G	
1	25695618	hydrochlorothiazide	C03AA03	efficacy	blood pressure			GENRES, GERA, NORDIL, PEAR, CSN-StayOnDiur		G	
1	24816038	pravastatin	C10AA03	efficacy	incidence of cardiovascular events			PHASE, PROSPER, CARE, WOSCOPS		G	
1	27993963	Anthracyclines and related substances	L01DB	side effects	heart failure			N/A		G	
1	19667218	interferon beta-1a	L03AB07	efficacy	Expanded Disability Status Scale			N/A		G	
1	26656879	Other antipsychotics in ATC	N05AX	side effects	weight gain			N/A		G	
1	23392654	Acetylsalicylic acid	A01AD05	efficacy	incidence of cardiovascular events			PAPI, INVEST, INVEST-GENES		G	
1	21061259	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score			WTCCC		G	
1	25503805	heparin	B01AB01	side effects	thrombocytopenia			BioVu, SHIP		G	
1	19483685	flucloxacillin	J01CF05	side effects	drug-induced liver injury			DILIGEN		G	
1	25096692	phenytoin	N03AB02	side effects	SJS, TEN			CGMH		G	
1	25218607	melphalan	L01AA03	side effects	oral mucositis		melphalan along with autologous stem cell transplant	N/A		G	
1	27704462	dendritic cell-based immunotherapy	N/A	efficacy	Viral load			N/A		G	
1	19736353	ANTIDEPRESSANTS	N06A	efficacy	HAM-D			MARS, STAR*D\		G	
1	27114598	Asparaginase	L01XX02	side effects	pancreatitis			SJCRH		G	
1	17505501	ximelagatran	B01AE05	side effects	serum alanine aminotransferase			EXGEN, LTT		G	
1	25914168	interferon beta-1a	L03AB07	efficacy	Response based on MRI			WTCCC2		G	
1	22566560	ANTIPSYCHOTICS	N05A	side effects	weight gain			N/A		G	
1	25781442	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	M01A	side effects	colorectal cancer incidence		nsaids	CCFR, DACHS, DALS, HPFS, NHS, OFCCR, GECCO		G	
1	21072201	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	M01A	side effects	forced expiratory volume		nsaids	N/A		G	
1	29246731	delta-6 desaturase	N/A	biomarker	triglyceride levels 		response to enzyme	N/A		G	
1	24847101	Vitamin A and D in combination	A11CB	biomarker	triglyceride levels 		cod liver oil	FINGEN		G	
4	21755009	Cytarabine	L01BC01	efficacy	cytotoxicity	TRUE		N/A		G	
4	21755009	fluorouracil	L01BC02	efficacy	cytotoxicity	TRUE		N/A		G	
4	21755009	Carboplatin	L01XA02	efficacy	cytotoxicity	TRUE		N/A		G	
4	21755009	Cisplatin	L01XA01	efficacy	cytotoxicity	TRUE		N/A		G	
1	22843789	paclitaxel	L01CD01	side effects	peripheral neuropathy			CALGB, PGRN-RIKEN		S	
1	21705454	Platinum compounds, antineoplastic drugs	L01XA	efficacy	cytotoxicity	TRUE		AOCS		G	
1	23233654	Tumor necrosis factor alpha (TNF-a) inhibitors	L04AB	efficacy	Disease Activity Score			DREAM, WTCCC, ReAct, REF, ABCoN, AMC, BRAGGSS, BeSt, BRASS, EIRA, ERA, KI, READE, TEAR		G	
1	23962720	ANTIEPILEPTICS	N03	efficacy	frequency of seizures			SANAD		G	
1	21497773	Platinum compounds, antineoplastic drugs	L01XA	efficacy	cytotoxicity	TRUE		N/A		G	
1	19724244	citalopram	N06AB04	side effects	suicidal ideation			STAR*D		G	
1	21775533	Cisplatin	L01XA01	efficacy	cytotoxicity	TRUE		N/A		G	
1	25015694	multiple	N/A	efficacy	heart rate		atrioventribular nodal blockers	VAFR, BioVU, PGRN-RIKEN		S	
1	26190474	trichloroethylene	N01AB05	side effects	drug-induced hypersensitivity			N/A		G	
1	18195134	interferon beta-1a	L03AB07	efficacy	Expanded Disability Status Scale			N/A		G	
1	23992748	salbutamol	R03AC02	efficacy	Forced expiratory volume			GALA II, GALA I		G	
1	26821981	ANTIPSYCHOTICS	N05A	efficacy	Maintenance dose			N/A		G	
1	24595012	capecitabine	L01BC06	side effects	hand-foot syndrome	TRUE	combined cell line and patient analysis	N/A		G	
1	22267851	bisphosphonate drugs affecting bone structure and mineralization	M05BA	side effects	osteonecrosis			N/A		G	
1	25624441	mercaptopurine	L01BB02	efficacy	dose intensity			COG, SJCRH		G	
1	29795407	methotrexate	L01BA01	efficacy	swollen 28-joint count, tender 28-joint count, C-reactive protein and the overall 3-component disease activity score			MATURA, PAMERA, YEAR, RAMS, IACON, IDEA, EMPIRE, CARDERA-1, TEAR, SWEFOT, AMBITION, PGRN-RIKEN		S	
1	29768301	bevacizumab	L01XC07	efficacy	survival			N/A, PGRN-RIKEN		S	
1	25148458	Aromatase inhibitors	L02BG	side effects	bone fracture incidence			N/A, PGRN-RIKEN		S	
1	29653637	clopidogrel	B01AC04	efficacy	platelet function			ICPC, P-STAR, PGRN-RIKEN		S	
1	28611204	Cisplatin	L01XA01	side effects	peripheral neuropathy			The Platinum Study, PGRN-RIKEN		S	
1	30664875	multiple	N/A	side effects	drug-induced liver injury			DILIN, iDILIC		G	
1	30467200	Asparaginase	L01XX02	side effects	pancreatitis			Ponte di Legno, ALL		G	
1	29871907	bevacizumab	L01XC07	side effects	hypertension			CALGB		G	 
1	31033190	BETA BLOCKING AGENTS	C07A	efficacy	blood pressure			PEAR, PEAR-2		G	
1	27859023	metformin	A10BA02	efficacy	HbA1c levels			MetGen Consortia, GoDARTS, PMT2-EU, Riga, Rotterdam, PGRN-RIKEN		G	
1	27088321	Nucleoside and nucleotide reverse transcriptase inhibitors	J05AF	biomarker	plasma kynurenine/tryptophan ratio			UARTO, ARKS, PGRN-RIKEN		S	
1	26903268	Selective serotonin reuptake inhibitors	N06AB	biomarker	plasma serotonin concentration			PGRN-AMPS, PGRN-RIKEN		S	
1	26734457	Glucocorticoid inhalants for obstructive airway disease	R03BA	efficacy	asthma incidence			BioVU, PMRP, PGRN-RIKEN		S	
1	26425837	atenolol	C07AB03	efficacy	blood pressure			PEAR, GENRES, INVEST, PGRN-RIKEN		S	
1	26252367	Antihypertensives for pulmonary arterial hypertension	C02KX	efficacy	Comprehensive objective measures including a 6-minute-walk test, Borg dyspnea score, functional class, and laboratory studies			STRIDE, PGRN-RIKEN		S	
1	23518928	Aromatase inhibitors	L02BG	biomarker	plasma estradiol			N/A, PGRN-RIKEN		S	
1	32958699	ANTINEOPLASTIC AGENTS	L01	efficacy	survival		Combination of various anti-cancer drugs	CALGB, PGRN-RIKEN		S	
1	30610379	selective serotonin reuptake inhibitors	N06AB	side effects	obesity, CAD			ISPC, STAR*D, PGRN-RIKEN		S	
1	18594024	bisphosphonate	M05BA	side effects	osteonecrosis		combination of various biphosphate	N/A		S	
1	18334916	ANTIPSYCHOTICS	N05A	side effects	tardive dyskinesia		combination of antipyschotics for schizophrenia	N/A		S	
1	18821564	methylphenidate	N06BA04	efficacy	change in ADHD-RS score from baseline			N/A		S	
1	17673902	etoposide	L01CB01	side effects	secondary leukemia			N/A		S	
1	33058932	Beta-lactam antibiotic	J01C	side effects	hypersensitivity reactions			N/A		S	
1	32128760	atorvastatin	C10AA05	biomarker	drug levels			N/A		S	
1	30661239	flucloxacillin	J01CF05	side effects	drug induced liver injury			International Drug-Induced Liver Injury Consortium (iDILIC)		S	
